Carsten Brunn - Net Worth and Insider Trading

Carsten Brunn Net Worth

The estimated net worth of Carsten Brunn is at least $518,928 dollars as of 2024-12-27. Carsten Brunn is the President and CEO of Cartesian Therapeutics Inc and owns about 26,103 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $518,928. Details can be seen in Carsten Brunn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carsten Brunn has not made any transactions after 2023-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carsten Brunn

To

Carsten Brunn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carsten Brunn owns 2 companies in total, including Cartesian Therapeutics Inc (RNAC) , and Surface Oncology Inc (SURF) .

Click here to see the complete history of Carsten Brunn’s form 4 insider trades.

Insider Ownership Summary of Carsten Brunn

Ticker Comapny Transaction Date Type of Owner
RNAC Cartesian Therapeutics Inc 2023-09-25 director & President & CEO
SURF Surface Oncology Inc 2022-06-28 director

Carsten Brunn Latest Holdings Summary

Carsten Brunn currently owns a total of 1 stock. Carsten Brunn owns 26,103 shares of Cartesian Therapeutics Inc (RNAC) as of September 25, 2023, with a value of $518,928.

Latest Holdings of Carsten Brunn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RNAC Cartesian Therapeutics Inc 2023-09-25 26,103 19.88 518,928

Holding Weightings of Carsten Brunn


Carsten Brunn Form 4 Trading Tracker

According to the SEC Form 4 filings, Carsten Brunn has made a total of 14 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Cartesian Therapeutics Inc is the sale of 98 shares on September 25, 2023, which brought Carsten Brunn around $3,108.

Insider Trading History of Carsten Brunn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carsten Brunn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carsten Brunn Ownership Network

Ownership Network List of Carsten Brunn

No Data

Ownership Network Relation of Carsten Brunn

Insider Network Chart

Carsten Brunn Owned Company Details

What does Cartesian Therapeutics Inc do?

Who are the key executives at Cartesian Therapeutics Inc?

Carsten Brunn is the director & President & CEO of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , Chief Scientific Officer Takashi Kei Kishimoto , and COO and SVP & R&D Lloyd P. Johnston .

Cartesian Therapeutics Inc (RNAC) Insider Trades Summary

Over the past 18 months, Carsten Brunn made 1 insider transaction in Cartesian Therapeutics Inc (RNAC) with a net sale of 2,932. Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,921,182 shares made by Timothy A Springer , a net sale of 52,115 shares made by , and a net purchase of 7,500 shares made by Timothy C Barabe .

In summary, during the past 3 months, insiders sold 241,836 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 689,850 shares, with a net purchase of 448,014 shares. During the past 18 months, 241,957 shares of Cartesian Therapeutics Inc (RNAC) were sold and 746,143 shares were bought by its insiders, resulting in a net purchase of 504,186 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cartesian Therapeutics Inc Insider Transactions

No Available Data

Carsten Brunn Mailing Address

Above is the net worth, insider trading, and ownership report for Carsten Brunn. You might contact Carsten Brunn via mailing address: C/o Selecta Biosciences, Inc., 480 Arsenal Way, Watertown Ma 02472.

Discussions on Carsten Brunn

No discussions yet.